New discovery paves way for effective malaria vaccineJune 18th, 2010 - 2:01 pm ICT by ANI
Washington, June 18 (ANI): An international team of researchers has made a novel discovery that offers new hope for an effective vaccine against malaria in the future.
Plasmodium falciparum, a blood parasite that causes malaria by invading and multiplying in the red blood cells, kills 1 to 2 million people annually.
“How the parasite invades red blood cells is not completely understood. For many years it has been known that proteins called glycophorins are used by the parasite to gain entry into the red cell,” said Jose A. Stoute, senior investigator and team leader, Department of Medicine, Division of Infectious Diseases and Epidemiology, Penn State College of Medicine.
Because infection can take place without glycophorins, researchers suspected that another protein is also involved. The identity of this protein remained a mystery for 20 years and it was named the “X” receptor.
A team of researchers now reports the identity of this protein as the complement receptor 1 (CR1), also known to help protect red cells from attack by the immune system.
CR1 has been suspected of having other roles in the development of malaria complications.
The team was able to demonstrate that this protein is important in the invasion of red cells by using several laboratory strains of malaria as well as strains obtained from Kenya.
“Our findings suggest that for many malaria strains, CR1 is an alternative receptor to glycophorins on intact red cells,” Stoute said.
According to the researchers, the reasons malaria may use the CR1 protein instead of glycophorins are if the parasite encounters a variant that lacks the glycophorin receptor; if the immune system mounts a response against parasite proteins involved in the dominant pathway due to a previous infection; or if the host were to be vaccinated with a vaccine that blocks the glycophorin pathway.
“This work has important implications for the future development of a vaccine against malaria. Therefore, it is imperative that all the major invasion pathways be represented in a future malaria blood stage vaccine,” Stoute said.
Vaccines that target parasite proteins involved in the dominant glycophorin pathway, but do not block the CR1 pathway, may cause proliferation of parasites that rely on the CR1 pathway for infection.
Carmenza Spadafora, lead author and scientist at the Institute for Advanced Science and High Technology Studies, Republic of Panama, said: “The demonstration that CR1 is a receptor of P. falciparum will facilitate the identification of additional parasite proteins that allow it to bind to the blood cell, and the future development of a vaccine that effectively blocks red cell invasion.”
The study has been published in June 17 issue of PLoS Pathogens. (ANI)
- New pathway used by malaria parasite to infect human cells identified - Sep 25, 2010
- Scientists closer to developing anti-malaria shot - Aug 06, 2012
- New way found to kill malaria parasite - Mar 09, 2011
- New discovery opens up novel strategy for combating malaria - Mar 09, 2011
- Scientists locate malaria parasites' Achilles heal - Apr 22, 2012
- Malaria-infected cells stiffen, block blood flow to brain and other organs - Dec 21, 2010
- How malaria parasite and red blood cells interact - Mar 11, 2009
- Vaccine slashes malaria risk by half - Jan 14, 2011
- Blood-thinning drug can stop malaria infection - Jun 02, 2010
- Re-engineering mosquito's immunity to block malaria - Dec 29, 2011
- Breakthrough may pave way for new malaria drugs - Nov 27, 2011
- Modified bone drug kills malaria parasite - Feb 28, 2012
- Protein group prime candidate for potent malaria vaccine - Jan 19, 2010
- Discovery could lead to 'next-gen' vaccines - Apr 08, 2012
- Malaria came from gorillas thousands of years ago - Sep 24, 2010
Tags: blood parasite, college of medicine, complement, cr1, future development, immune system, infectious diseases, laboratory strains, malaria vaccine, medicine division, new discovery, new hope, pathway, penn state college, penn state college of medicine, plasmodium falciparum, proteins, red blood cells, red cells, team leader